- Published on
Pharmacology - Warfarin
This prevents the blood from coagulating.
Mode of Action
Performs the function of inhibiting the reduction of vitamin K, which in turn prevents the gamma carboxylation of the glutamate residues found in factors II, VII, IX, and X.
Orally administered. The degrading of the circulating gamma-carboxylated substances is the reason for the gradual onset of the condition. A monitoring of the prothrombin time is required. The action of numerous medications, such as ciprofloxacin and aspirin, was boosted, which resulted in an increased risk of bleeding. Many medications, such as rifampicin, have been shown to reduce the action, which in turn reduces the chance of clotting.
Use in Clinical Settings
For the purpose of treating pulmonary embolism and deep vein thrombosis. So as to avoid embolization in patients with atrial fibrillation.
Adverse Reactions
There is a treatment for bleeding that involves administering natural vitamin K, fresh plasma, or coagulation factor concentrates.
This prevents the blood from coagulating.
Mode of Action
Performs the function of inhibiting the reduction of vitamin K, which in turn prevents the gamma carboxylation of the glutamate residues found in factors II, VII, IX, and X.
Orally administered. The degrading of the circulating gamma-carboxylated substances is the reason for the gradual onset of the condition. A monitoring of the prothrombin time is required. The action of numerous medications, such as ciprofloxacin and aspirin, was boosted, which resulted in an increased risk of bleeding. Many medications, such as rifampicin, have been shown to reduce the action, which in turn reduces the chance of clotting.
Use in Clinical Settings
For the purpose of treating pulmonary embolism and deep vein thrombosis. So as to avoid embolization in patients with atrial fibrillation.
Adverse Reactions
There is a treatment for bleeding that involves administering natural vitamin K, fresh plasma, or coagulation factor concentrates.
0 Comments
